![](/img/cover-not-exists.png)
Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer
Leung, P. P., Tannock, I. F., Oza, A. M., Puodziunas, A., Dranitsaris, G.Volume:
17
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1999.17.10.3082
Date:
October, 1999
File:
PDF, 127 KB
english, 1999